Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ironwood Pharmaceuticals, Inc. - Class A Common Stock (NQ:IRWD)

0.6149 +0.0259 (+4.40%)
Streaming Delayed Price Updated: 2:42 PM EDT, May 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,214,267
Open 0.5880
Bid (Size) 0.6138 (2)
Ask (Size) 0.6159 (19)
Prev. Close 0.5890
Today's Range 0.5700 - 0.6241
52wk Range 0.5271 - 7.105
Shares Outstanding 160,028,388
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Ironwood Pharma Stock Draws Retail Investor Ire With Big Q1 Miss And No Earnings Call
The drugmaker’s first-quarter revenue of $41.1 million came in well below the consensus estimate of $56.7 million, attributed to changes in AbbVie’s gross-to-net rebate reserves. 
Via Stocktwits
Topics Earnings
Exposures Financial
Ironwood Pharmaceuticals Reports First Quarter 2025 Results
From Ironwood Pharmaceuticals, Inc.
Via Business Wire

Performance

YTD
-85.8%
-85.8%
1 Month
-12.8%
-12.8%
3 Month
-68.3%
-68.3%
6 Month
-82.5%
-82.5%
1 Year
-90.9%
-90.9%

More News

Read More
Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
Earnings Scheduled For February 27, 2025
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
This General Motors Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Via Benzinga
Which stocks are moving on Monday?
Via Chartmill
Ironwood Pharmaceuticals Stock Plunges, FDA Wants Another Trial For Gastrointestinal Drug
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Crude Oil Moves Lower; M&T Bank Earnings Miss Views
Via Benzinga
Topics Earnings
Exposures Financial Fossil Fuels
Gapping stocks in Monday's session
Via Chartmill
These stocks are moving in today's pre-market session
Via Chartmill
Nasdaq Surges 2%; Goldman Sachs Posts Upbeat Earnings
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call
From Ironwood Pharmaceuticals, Inc.
Via Business Wire
Let's take a look at the stocks that are in motion in today's session.
Via Chartmill
Top stock movements in today's session.
Via Chartmill
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
Curious about the stocks that are showing activity after the closing bell on Wednesday?
Via Chartmill
Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future
From Ironwood Pharmaceuticals, Inc.
Via Business Wire

Frequently Asked Questions

Is Ironwood Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Ironwood Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Ironwood Pharmaceuticals, Inc. - Class A Common Stock trade on?
Ironwood Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ironwood Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Ironwood Pharmaceuticals, Inc. - Class A Common Stock is IRWD on the Nasdaq Stock Market
What is the current price of Ironwood Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Ironwood Pharmaceuticals, Inc. - Class A Common Stock is 0.6149
When was Ironwood Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Ironwood Pharmaceuticals, Inc. - Class A Common Stock was at 05/22/25 02:42 PM ET
What is the market capitalization of Ironwood Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Ironwood Pharmaceuticals, Inc. - Class A Common Stock is 98.40M
How many shares of Ironwood Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Ironwood Pharmaceuticals, Inc. - Class A Common Stock has 98M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.